Viela Bio Competitors or Alternatives

Viela Bio's top competitors include Alexion, TG Therapeutics and AnTolRx.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Viela Bio's company profile

Bing Yao

Chairman & CEO

89/100
100 - 250
$507.4M
$100M - 500M
1
Viela Bio's Competitor - Alexion logo

Marc Dunoyer

CEO

- -
1,000 - 5,000
$18M
$5B - 10B
2
Viela Bio's Competitor - TG Therapeutics logo

Michael S. Weiss

Chairman & CEO

89/100
290
$603.1M
$329M
3
Viela Bio's Competitor - AnTolRx logo

Mark Carthy

Chairman & CEO

90/100
25 - 100
$5M
$5M - 25M
4
Viela Bio's Competitor - Exagen logo

John Aballi

President & CEO

55/100
220
$259.5M
$55.6M
5
Viela Bio's Competitor - BioGenex logo

Krishan L Kalra

Chairman & CEO

86/100
250 - 500
- -
$25M - 100M

Viela Bio VS Alexion

Alexion is Viela Bio's top competitor. Alexion is headquartered in Boston, Massachusetts, and was founded in 1992. Like Viela Bio, Alexion also operates in the Pharmaceuticals & Biotechnology field. Alexion generates 2,614% the revenue of Viela Bio.

Viela Bio VS TG Therapeutics

TG Therapeutics is seen as one of Viela Bio's top competitors. TG Therapeutics's headquarters is in Morrisville, North Carolina, and was founded in 1993. Like Viela Bio, TG Therapeutics also works within the Biotechnology industry. TG Therapeutics generates 136% of Viela Bio's revenue.

Viela Bio VS AnTolRx

AnTolRx has been one of Viela Bio's top competitors. AnTolRx was founded in 2014, and its headquarters is in Cambridge, Massachusetts. Like Viela Bio, AnTolRx also works within the Pharmaceuticals & Biotechnology field. AnTolRx has 125 fewer employees than Viela Bio.

Frequently Asked Questions about Viela Bio

  1. Who are Viela Bio's top competitors?

    Viela Bio's top 3 competitors are Alexion, TG Therapeutics, AnTolRx.
  2. Who is similar to Viela Bio?

    Alexion is the most similar to Viela Bio. TG Therapeutics and AnTolRx are also similar to Viela Bio.
  1. Are Viela Bio and Alexion competitors?

    Yes, Alexion is one of Viela Bio’s top competitors.